The table below shows SOLENO THERAPEUTICS INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
-
-
Cost of revenue
$1.20M
$1.14M
$696.00K
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$11.27M
$8.40M
$9.15M
$13.52M
$30.14M
$12.34M
SG&A
SLNO annual revenue (10-K history)
SOLENO THERAPEUTICS INC reported annual revenue of $1.45M for fiscal year 2016. That is up 138.8% from $607.47K in fiscal 2015. Figures come from the company's audited annual reports as filed with the SEC.